These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13472031)

  • 21. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations.
    Valentiner-Branth P; Perch M; Nielsen J; Steinsland H; Garly ML; Fischer TK; Sommerfelt H; Mølbak K; Aaby P
    Vaccine; 2007 Mar; 25(14):2733-41. PubMed ID: 16513227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002.
    Roth A; Sodemann M; Jensen H; Poulsen A; Gustafson P; Gomes J; Djana Q; Jakobsen M; Garly ML; Rodrigues A; Aaby P
    Vaccine; 2005 Jun; 23(30):3991-8. PubMed ID: 15899539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review].
    Toida I; Nakata S
    Kekkaku; 2007 Nov; 82(11):809-24. PubMed ID: 18078106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].
    Guthmann JP; de La Rocque F; Boucherat M; van Cauteren D; Fonteneau L; Lécuyer A; Cohen R; Lévy-Bruhl D
    Arch Pediatr; 2009 May; 16(5):489-95. PubMed ID: 19304464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis.
    Palmer MV; Thacker TC; Waters WR
    Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inequity in infant vaccination coverage in Colombia 2000 and 2003].
    Acosta-Ramírez N; Rodríguez-García J
    Rev Salud Publica (Bogota); 2006 May; 8 Suppl 1():102-15. PubMed ID: 16925125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles).
    Lesellier S; Palmer S; Dalley DJ; Davé D; Johnson L; Hewinson RG; Chambers MA
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):24-37. PubMed ID: 16687176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
    Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
    Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
    Artan R; Erol M; Velipasaoglu S; Yegin O
    Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG.
    Cross ML; Aldwell F
    Expert Rev Vaccines; 2007 Jun; 6(3):323-31. PubMed ID: 17542748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B.C.G., U.S.A.
    Lancet; 1966 Jun; 1(7452):1410-1. PubMed ID: 4160965
    [No Abstract]   [Full Text] [Related]  

  • 35. B. C. G. VACCINATION.
    Lancet; 1959 Jun; 1(7084):1190. PubMed ID: 13666013
    [No Abstract]   [Full Text] [Related]  

  • 36. [The B.C.G. vaccine].
    Erb-na-Bangxang
    Chot Mai Het Kan Phayaban; 1970 Jan; 19(1):36-9. PubMed ID: 5205000
    [No Abstract]   [Full Text] [Related]  

  • 37. B. C. G. VACCINATION in the U. S. A.
    Br Med J; 1957 Oct; 2(5051):989-90. PubMed ID: 13472031
    [No Abstract]   [Full Text] [Related]  

  • 38. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes.
    Buddle BM; Denis M; Aldwell FE; Martin Vordermeier H; Glyn Hewinson R; Neil Wedlock D
    Tuberculosis (Edinb); 2008 Nov; 88(6):595-600. PubMed ID: 18439875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis vaccinalis; report of two cases, one following B.C.G. vaccination and one following vaccination against influenza.
    RAASCHOU-NIELSEN W
    Acta Derm Venereol; 1955; 35(1):37-42. PubMed ID: 14387477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.